Literature DB >> 9059246

Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide.

J T Rosenbaum1, J Simpson, C M Neuwelt.   

Abstract

BACKGROUND: Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.
METHODS: Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.
RESULTS: All patients recovered excellent visual acuity.
CONCLUSION: Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059246      PMCID: PMC1722112          DOI: 10.1136/bjo.81.2.130

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

1.  [Supplementary findings on ophthalmological study of Takayasu's disease. Report II. Ischemic optic neuropathy associated with Takayasu's disease (author's transl)].

Authors:  M Ito
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1976

2.  BEHCET'S DISEASE; A REPORT OF 28 CASES.

Authors:  J G MAMO; A BAGHDASSARIAN
Journal:  Arch Ophthalmol       Date:  1964-01

3.  Optic neuritis and myelopathy in systemic lupus erythematosus.

Authors:  S Oppenheimer; B I Hoffbrand
Journal:  Can J Neurol Sci       Date:  1986-05       Impact factor: 2.104

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  [Two cases of retrobulbar neuritis and transverse myelopathy as the initial symptoms suggestive of systemic lupus erythematosus (SLE)--case report and review of literature].

Authors:  A Tamaoka; S Murayama; M Sonoh; K Matsumura; M Sakuta
Journal:  Rinsho Shinkeigaku       Date:  1986-05

6.  Autoimmune optic neuritis: a potentially treatable form of visual loss.

Authors:  W S Fleet; R T Watson
Journal:  Ann Ophthalmol       Date:  1986-04

7.  Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings.

Authors:  J G Kenik; K Krohn; R B Kelly; M Bierman; M D Hammeke; J A Hurley
Journal:  Arthritis Rheum       Date:  1987-08

8.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

9.  Optic neuropathy in systemic lupus erythematosus.

Authors:  D A Jabs; N R Miller; S A Newman; M A Johnson; M B Stevens
Journal:  Arch Ophthalmol       Date:  1986-04

10.  Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus.

Authors:  W J McCune; J Golbus; W Zeldes; P Bohlke; R Dunne; D A Fox
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

View more
  6 in total

Review 1.  Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease.

Authors:  T D Myers; J R Smith; M S Wertheim; R A Egan; W T Shults; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation.

Authors:  Asli Kurne; Ilksen Colpak Isikay; Kader Karlioguz; Umut Kalyoncu; Omer Faruk Aydin; Meral Calguneri; Rana Karabudak
Journal:  J Neurol       Date:  2009-01-21       Impact factor: 4.849

3.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02

4.  Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy.

Authors:  Pradeep Venkatesh; Varun Gogia; Shikha Gupta; Akshay Tayade; Neha Shilpy; Bhavin M Shah; Randeep Guleria
Journal:  Indian J Ophthalmol       Date:  2015-04       Impact factor: 1.848

5.  Concurrent Intracranial Hypertension and Bilateral Optic Neuritis in a Patient With Systemic Lupus Erythematosus: A Case Report.

Authors:  Worapot Srimanan; Somboon Panyakorn
Journal:  Clin Med Insights Case Rep       Date:  2022-09-06

6.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.